Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Contraception - Management
Under 18 years: how does this influence choice?

  • Provided that there are no medical contraindications, any method of contraception can be used, and a girl should choose her own method. However:
    • Before menarche: condoms are preferred for sexually active premenarchal girls (as a contraceptive, and to prevent sexually transmitted infection); hormonal methods are not advised.
    • Bone mineral density: a progestogen-only injectable may be used if the girl chooses this over other contraceptive methods.
    • Prevention of sexually transmitted infections: when a hormonal or intrauterine contraceptive method is chosen, condoms should also be used to prevent sexually transmitted infections.
  • Give advice about prevention of sexually transmitted infections.
    • The correct and consistent use of condoms should be advised to reduce the risk of sexually transmitted infections.
    • Young people should be advised to get tested for sexually transmitted infections 2 and 12 weeks after unprotected sexual intercourse.
  • Reassure girls and young women that:
    • Combined oral contraceptives (COCs) may improve acne vulgaris. Co-cyprindiol is indicated to treat severe acne which has not responded to oral antibiotics, but the higher risk of venous thromboembolism should be noted.
    • Any increase in risk of cancer associated with hormonal contraception is very small and not clinically relevant when weighed against the risk of pregnancy should contraception not be used.
    • The risk of venous thromboembolism is increased with use of COCs, but the absolute risk is very low.
    • There is no evidence of weight gain with use of COCs or the patch.
    • It is unclear whether hormonal contraception has an adverse effect on mood.
    • Altered bleeding patterns can occur with hormonal contraception, but dysmenorrhoea may improve with use of combined hormonal contraception.

In depth

© NHS Institute for Innovation and Improvement